Literature DB >> 23778973

Comparative analysis of the revenues of pylorus-preserving pancreatic head resections and laparoscopic cholecystectomies as prototypic surgical procedures in the German health-care system.

Tina Stellwag1, Christoph W Michalski, Bo Kong, Mert Erkan, Carolin Reiser-Erkan, Carsten Jäger, Christian Meinl, Helmut Friess, Jörg Kleeff.   

Abstract

BACKGROUND: Although centralization of complex surgical procedures such as pancreaticoduodenectomies is associated with a reduction in morbidity and mortality rates, it is unclear whether such surgeries are adequately represented in the German disease-related group (DRG) system. PATIENTS AND METHODS: Out of all patients who underwent pancreatic resections (n = 450) at our institution between January 2008 and November 2011, 76 patients who underwent a pylorus-preserving pancreatic head resection due to pancreatic head adenocarcinoma were selected for analysis. The revenues generated by these surgical procedures were compared with those of 144 patients who had undergone elective laparoscopic cholecystectomies for symptomatic gallstone disease between January 2009 and September 2010 in our hospital.
RESULTS: In patients undergoing pylorus-preserving pancreaticoduodenectomy, revenues per case were 1,585.55 Euros, with an average length of hospital stay (ALOS) of 19.9 days (range 7-55 days) and an average postoperative hospital stay of 16 days; however, if the ALOS was exceeded, expenditures increasingly exceeded returns. Analysis of the cohort of patients with pylorus-preserving pancreaticoduodenectomies demonstrated average revenues per day of 79.27 Euros. In contrast, for laparoscopic cholecystectomy, which was treated with high surgical standardization and stringent case management, the ALOS was only 2.8 days, producing average revenues of 288.80 Euros per day and total revenues of 817.53 Euros per case.
CONCLUSION: At university hospitals, cost-effective realization of major pancreatic surgery is difficult, while highly standardized surgeries such as laparoscopic cholecystectomies can be performed at a favorable balance. This may be due to, firstly, an underrepresentation of university hospitals in the German DRG calculation basis and, secondly, to a relatively long preoperative hospital stay as a result of extensive diagnostic measures. We consider this kind of preoperative assessment paramount for an academic pancreatic center and thus argue for an increased reimbursement for these procedures.

Entities:  

Mesh:

Year:  2013        PMID: 23778973     DOI: 10.1007/s00423-013-1091-4

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  31 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

Review 2.  Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands.

Authors:  N Tjarda van Heek; Koert F D Kuhlmann; Rob J Scholten; Steve M M de Castro; Olivier R C Busch; Thomas M van Gulik; Huug Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

3.  One thousand consecutive pancreaticoduodenectomies.

Authors:  John L Cameron; Taylor S Riall; JoAnn Coleman; Kenneth A Belcher
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

4.  One hundred and seventy-eight consecutive pancreatoduodenectomies without mortality: role of the multidisciplinary approach.

Authors:  Jaswinder S Samra; Raul Alvarado Bachmann; Julian Choi; Anthony Gill; Michael Neale; Vikram Puttaswamy; Cameron Bell; Ian Norton; Sarah Cho; Steven Blome; Ritchie Maher; Sivakumar Gananadha; Thomas J Hugh
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2011-08

5.  Improving outcome for patients with pancreatic cancer through centralization.

Authors:  V E P P Lemmens; K Bosscha; G van der Schelling; S Brenninkmeijer; J W W Coebergh; I H J T de Hingh
Journal:  Br J Surg       Date:  2011-06-29       Impact factor: 6.939

6.  Cost-utility estimation of surgical treatment of pancreatic carcinoma aimed at cure.

Authors:  David Ljungman; Kent Lundholm; Anders Hyltander
Journal:  World J Surg       Date:  2011-03       Impact factor: 3.352

7.  Cost analysis of pancreatic carcinoma treatment.

Authors:  W Du; D Touchette; V K Vaitkevicius; W P Peters; A F Shields
Journal:  Cancer       Date:  2000-11-01       Impact factor: 6.860

Review 8.  Economic evaluations of gastric and pancreatic cancer.

Authors:  A Elixhauser; M T Halpern
Journal:  Hepatogastroenterology       Date:  1999 Mar-Apr

9.  The cost of treating pancreatic cancer--a cohort study based on patients' records from four hospitals in Sweden.

Authors:  Jonas Hjelmgren; Jeanette Ceberg; Ulf Persson; Thor A Alvegård
Journal:  Acta Oncol       Date:  2003       Impact factor: 4.089

10.  Effect of centralization of pancreaticoduodenectomy on nationwide hospital mortality and length of stay.

Authors:  B Topal; S Van de Sande; S Fieuws; F Penninckx
Journal:  Br J Surg       Date:  2007-11       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.